Clopidogrel use and short-term mortality after peptic ulcer bleeding: A population-based cohort study

American Journal of Therapeutics

Volumn 20, Issue 1, 2013, Pages 13-20

  Schmidt, Morten ^a   Riis, Anders H ^a   Christiansen, Christian F ^a   Lash, Timothy L ^a   Sørensen, Henrik T ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

clopidogrel; cohort study; mortality; peptic ulcer hemorrhage; prognosis

Indexed keywords

CLOPIDOGREL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; COHORT ANALYSIS; COMORBIDITY; DENMARK; DRUG USE; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PEPTIC ULCER BLEEDING; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; COHORT STUDIES; DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER HEMORRHAGE; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; TICLOPIDINE;

EID: 84872963580     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3181ff7ad1     Document Type: Article

References (36)

1. Kushner FG, Hand M, Smith SC, et al. Focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): A report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation. 2009;120:2271-2306
2. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: A report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/non STelevation myocardial infarction): Developed in collaboration with the American college of emergency physicians, the society for cardiovascular angiography and interventions, and the society of thoracic surgeons: Endorsed by the American association of cardiovascular and pulmonary rehabilitation and the society for academic emergency medicine. Circulation. 2007;116:e148-e304
3. Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352:1179-1189 (Pubitemid 40397259)
4. Steinhubl SR, Berger PB, Mann JT, et al. Credo investigators. Clopidogrel for the reduction of events during observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. JAMA. 2002; 288:2411-2420 (Pubitemid 35340537)
5. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502 (Pubitemid 32758501)
6. Sørensen R, Hansen ML, Abildstrom SZ, et al. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: A retrospective analysis of nationwide registry data. Lancet. 2009;374: 1967-1974
7. Hallas J, Dall M, Andries A, et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: Population based casecontrol study. BMJ. 2006;333:726
8. Vallurupalli NG, Goldhaber SZ. Gastrointestinal complications of dual antiplatelet therapy. Circulation. 2006;113: E655-e6558
9. Barkun AN, Bardou M, Kuipers EJ, et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2010;152:101-113
10. Helø OH, Madsen JK, Kastrup J. [Treatment of ischemic heart disease with the platelet aggregation inhibitor clopidogrel]. Ugeskr Laeger. 2004;166:1659-1662
11. Frank L. Epidemiology. When an entire country is a cohort. Science. 2000;287:2398-2399 (Pubitemid 30185417)
12. Andersen TF, Madsen M, Jorgensen J, et al. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46:263-268 (Pubitemid 29299976)
13. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet. 2007;370:1453-1457
14. Gaist D, Sorensen HT, Hallas J. The Danish prescription registries. Dan Med Bull. 1997;44:445-458
15. Available drugs and package sizes on the Danish drug market. Available at: Http://www.lmk.dk. January 9, 2010
16. Pedersen CB, Gøtzsche H, Møller JO, et al. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 2006;53:441-449 (Pubitemid 44816920)
17. Mose H, Larsen M, Riis A, et al. Thirty-day mortality after peptic ulcer bleeding in hospitalized patients receiving low-dose aspirin at time of admission. Am J Geriatr Pharmacother. 2006;4:244-250 (Pubitemid 44575964)
18. Thomsen RW, Riis AF, Christensen S, et al. Outcome of peptic ulcer bleeding among users of traditional nonsteroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors. Aliment Pharmacol Ther. 2006;24: 1431-1438 (Pubitemid 44657119)
19. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40: 373-383 (Pubitemid 17055592)
20. de Groot V, Beckerman H, Lankhorst GJ, et al. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol. 2003;56:221-229 (Pubitemid 36513483)
21. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619
22. D'Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol 1996;49: 1429-1433 (Pubitemid 27028932)
23. Blot WJ, Fischer T, Nielsen GL, et al. Outcome of upper gastro-intestinal bleeding and use of ibuprofen versus paracetamol. Pharm World Sci. 2004;26:319-323
24. Dalton SO, Sørensen HT, Johansen C. SSRIs and upper gastrointestinal bleeding: What is known and how should it influence prescribing? CNS Drugs. 2006;20:143-151 (Pubitemid 43261698)
25. Gulløv AL, Koefoed BG, Petersen P. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: The AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation. Arch Intern Med. 1999;159: 1322-1328 (Pubitemid 29293594)
26. Kaplan RC, Heckbert SR, Koepsell TD, et al. Use of calcium channel blockers and risk of hospitalized gastrointestinal tract bleeding. Arch Intern Med. 2000; 160:1849-1855 (Pubitemid 30418824)
27. Nielsen GL, Sorensen HT, Mellemkjoer L, et al. Risk of hospitalization resulting from upper gastrointestinal bleeding among patients taking corticosteroids: A register-based cohort study. Am J Med. 2001;111:541-545 (Pubitemid 33052352)
28. Sørensen HT, Mellemkjaer LF, Blot WJ, et al. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol. 2000;95:2218-2224
29. Christiansen C, Christensen S, Riis AF, et al. Antipsychotic drugs and short-Term mortality after peptic ulcer perforation: A population-based cohort study. Aliment Pharmacol Ther. 2008;28:895-902
30. Tørring ML, Riis A, Christensen S, et al. Perforated peptic ulcer and short-Term mortality among tramadol users. Br J Clin Pharmacol. 2008;65:565-572 (Pubitemid 351365121)
31. Dikman A, Sanyal S, Von Althann C, et al. A randomized, placebo-controlled study of the effects of naproxen, aspirin, celecoxib or clopidogrel on gastroduodenal mucosal healing. Aliment Pharmacol Ther. 2009;29: 781-791
32. Sørensen HT. Regional administrative health registers as a resource in clinical epidemiology. A study of options, strengths, limitations and data quality provided with examples of use. Int J Risk Safety Med. 1997;10:1-22
33. Lopushinsky SR, Covarrubia KA, Rabeneck L, et al. Accuracy of administrative health data for the diagnosis of upper gastrointestinal diseases. Surg Endosc. 2007;21: 1733-1737 (Pubitemid 47404096)
34. Margulis AV, Garc'ia Rodr'iguez LA, Herna'ndez-D'iaz S. Positive predictive value of computerized medical records for uncomplicated and complicated upper gastrointestinal ulcer. Pharmacoepidemiol Drug Saf. 2009; 18:900-909
35. Cattaruzzi C, Troncon MG, Agostinis L, et al. Positive predictive value of ICD-9th codes for upper gastrointestinal bleeding and perforation in the Sistema Informativo Sanitario Regionale database. J Clin Epidemiol. 1999;52: 499-502 (Pubitemid 29281666)
36. Lanas A, Garc'ia-Rodr'iguez LA, Polo-Tomá s M, et al. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol. 2009;104:1633-1641